<DOC>
	<DOCNO>NCT00142051</DOCNO>
	<brief_summary>Randomized , double blind placebo control clinical trial evaluate effectiveness safety inhale nitric oxide treatment sickle cell painful crisis pediatric patient sickle cell disease .</brief_summary>
	<brief_title>Inhaled Nitric Oxide Pediatric Painful Sickle Crisis</brief_title>
	<detailed_description>The specific aim study evaluate clinical effectiveness inhale nitric oxide ( INO ) treatment acute vaso-occlusive pain crisis pediatric patient sickle cell disease . Nitric oxide ( NO ) deficiency know central pathophysiology vaso-occlusion . The aim unchanged original application . The study randomize , double blind , placebo control , clinical trial eligible patient randomize receive either NO ( 21 % O2 final concentration ) 16 hr 8 hr wean ( 80 ppm 0-8 hr , 40 ppm 9-16 hr , 20 ppm 17-20 hr , 10 ppm 21-24 hr ) placebo ( 21 % O2 alone ) 24 hr . The null hypothesis difference change mean pain score 16 hour patient treat NO placebo . The primary outcome measure study remain difference mean change pain score group assess use 10 cm visual analogue pain scale ( VAS ) . Secondary outcome measure also remain . The study next step complete FDA Orphan Product Development Grant fund study ( FD-R-001686 ) evaluate safety efficacy NO use 4 hrs treatment vaso-occlusive crisis pediatric patient sickle cell disease .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>1 . Hemoglobin SS , Hemoglobin Sß0thal Hemoglobin SC document prior hemoglobin electrophoresis . 2 . Age 9 year great , age 22 year less ; pediatric age range , old enough comply mask give reliable pain assessment score . 3 . Acute pain crisis define pain abdomen , back and/or extremity explain diagnosis sickle cell disease . 4 . Initial pain score least 6 cm ; optimize likelihood observe significant difference change pain score INO treat placebo group . Based data previous study , anticipated patient average preinhalation pain score approximately 8 cm . 1 . &gt; 24 pain crisis last 12 month . Patients frequent pain crisis may biologic and/or psychosocial pathophysiology differs fewer pain crisis . 2 . Pain crisis treat medical facility within last 12 hour . 3 . Use investigational drug hydroxyurea within last 30 day . 4 . Significant respiratory compromise ( initial SaO2 &lt; 90 % ) and/or patient likely acute chest syndrome ( chest pain infiltrate ) eliminate . 5 . Clinically significant acute chronic cardiac dysfunction . 6 . Acute priapism . 7 . New focal neurologic symptom . 8 . Concurrent document suspected bacterial parvovirus infection . 9 . Temperature &gt; 38.4ºC . These patient may concomitant infection . 10 . Transfusion within 30 day chronic transfusion therapy . 11 . Pregnant female 12 . Cigarette smoker &gt; 1/2 ppd . 13 . Allergy morphine</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>sickle cell disease</keyword>
	<keyword>pain crisis</keyword>
	<keyword>vaso-occlusive crisis</keyword>
	<keyword>nitric oxide</keyword>
</DOC>